Navigation Links
Genta Clinical Programs Featured at American Society of Hematology Meeting
Date:12/4/2007

Phase 3 CLL Survival Analysis Selected for ASH Press Briefing

BERKELEY HEIGHTS, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced that several abstracts related to the Company's clinical programs will be featured at the annual meeting of the American Society of Hematology (ASH) in Atlanta, GA during December 7-11, 2007. Programs involving Genasense(R) (oblimersen sodium) Injection, Genta's lead anticancer compound, and G4544, a new oral drug for bone diseases, were released in abstracts published in the meeting proceedings, as follows:

-- Addition of oblimersen (Bcl-2 antisense) to

fludarabine/cyclophosphamide for relapsed/refractory chronic

lymphocytic leukemia extends survival in patients who achieve CR/nPR:

Results from a randomized Phase 3 study.

Oral session: Tuesday, December 11, 2007; 7:30 am

Note: This abstract has been selected for a featured press briefing

sponsored by ASH on Sunday December 9 at 9:30 am.

-- Oblimersen (Genasense(R)), a phosphorothioate Bcl-2 antisense

oligonucleotide (ASO), can be safely administered by bolus subcutaneous

(SC) injection and brief IV Infusion. Publication.

-- Phase 1 assessment of G4544, an orally bioavailable formulation of

gallium nitrate. Publication.

About Genasense

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced apoptosis (programmed cell death). By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment. Genta is pursuing a broad clinical development program with Genasense
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... ALBANY, N.Y. , Oct. 20, 2014 ... pharmaceutical outsourcing facility in Albany, NY ... and trials. The company meets and/or exceeds the FDA ... 210 and 21 CFR Part 211. ... provide the highest levels of quality assurance and quality ...
(Date:10/19/2014)... -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) ... 2014 financial results on Wednesday, October 29, 2014, after ... announcement, members of the management team will host a ... a general corporate update at 4:30 p.m. EDT (1:30 ... as follows: Wednesday, October 29 1:30 ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
Breaking Medicine Technology:CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... , MINNETONKA, Minn., Dec. 1 ... company specializing in clinical study management systems, today ... technology solution, has been certified by the Clinical ... the Operational Data Model (ODM) standard. This ...
... , CAMBRIDGE, Mass. and TOKYO, Dec. 1 Galenea ... further extension of their research and development collaboration through ... to seven years and brings the total committed funding ... working together since January 2005 with the goal of ...
Cached Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3
(Date:10/20/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... The new module enables easy administration and routing of ... care. , This application allows users such as Therapists ... a to-do item to a specific client, categorize tasks ... reoccurring reminders for follow-ups. It's designed to enable ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Sit and Slim ... 10 not to purchase or use Sit and Slim II ... Slim II is promoted as weight loss product on various ... from the market in 2010 for safety reasons, can significantly ...
(Date:10/20/2014)... Rockynol Retirement Community broke ... 14. The $11 million project will include the latest ... kitchen with full-service restaurant style dining. , “We are ... class Assisted Living apartments,” said Kara Hanzie, Rockynol Executive ... quality of care and this investment is proof of ...
(Date:10/20/2014)... Fort Collins, CO (PRWEB) October 20, 2014 ... platform, dGH assays are the only imaging assays ... data in a single test.  With these three ... in their ability to detect the widest range ... chromosomal translocations—mutations usually missed by other genomic tools, ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from Pixel Film ... FCPX filmmakers . , “Fun, cool, and simple are ... Says Christina Austin, CEO of Pixel Film Studios. “It has ... comes with all the tools needed for a full ... added style, a title screen for an introduction, two lower ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2
... the 12 Million Americans With Food Allergy, FAIRFAX, ... (FAAN) will sponsor an educational briefing on Capitol,Hill to ... honor of,the 11th annual Food Allergy Awareness Week, May ... the challenges of food allergy,through five steps aimed at ...
... Va., May 8 Pending cuts to the,Medicare ... of,physical therapists to serve the rehabilitation needs of ... costs while decreasing quality of,care, according to the ... Section., In testimony May 8 before a ...
... gruesome,discovery of aborted babies in a dumpster behind Dr. ... a Pro-Life Society,discovered the mutilated bodies of aborted babies ... owned by Dr. Reginald Sharpe., "It is indeed ... that we,must stop and take time to grieve the ...
... Tenn., May 8 TeamHealth Inc.,s parent,company, Team ... the,first quarter ended March 31, 2008., The ... anesthesia,management services business line and substantially completed the ... of 2007. As a result, in,accordance with relevant ...
... Care Conference on May 13 - ... on May 14 -, SAN DIEGO, May 8 Gen-Probe Incorporated,(Nasdaq: ... Bank of,America 2008 Health Care Conference in Las Vegas on May 13, ... the Baird,Growth Stock Conference in Chicago on May 14, 2008 at approximately ...
... increased odds of heart attack, death, study finds , , THURSDAY, ... doctor can hear when passing a stethoscope over a main ... heart attack and death from heart disease and stroke, a ... bruit (pronounced brew-ee) -- is caused by turbulent blood flow ...
Cached Medicine News:Health News:Five Steps Forward for Food Allergy 2Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 2Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 3Health News:Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress 4Health News:ALL: More Dead Babies Found in Michigan Dumpsters 2Health News:Team Finance LLC Announces First Quarter 2008 Results 2Health News:Team Finance LLC Announces First Quarter 2008 Results 3Health News:Team Finance LLC Announces First Quarter 2008 Results 4Health News:Team Finance LLC Announces First Quarter 2008 Results 5Health News:Team Finance LLC Announces First Quarter 2008 Results 6Health News:Team Finance LLC Announces First Quarter 2008 Results 7Health News:Gen-Probe to Webcast Two Upcoming Investor Presentations 2Health News:Noise in Artery Could Warn of Heart Risk 2
... Re-insulation capabilities that extend the life ... that bring them back to life, expertise ... Instrument trademark. Our maintenance capabilities always help ... , Economical and fast, not only do ...
Inquire...
... your camera upon arrival.,Our technician then makes note ... with a thorough customer quote. We respect that ... so well help you prioritize repairs. With customer ... , ISI uses only OEM or widely approved ...
... an ISI technician carefully inspects your ... and all problems, and provides you ... respect that you may be working ... help you prioritize repairs. With customer ...
Medicine Products: